Skip To Main Content
Rebecca Barty on Muck Rack

Rebecca Barty

As seen in: Color Research & Application, Wiley Online Library, Chest
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rebecca

Contact Rebecca, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reducing blood product wastage through the inter‐hospital redistribution of near‐outdate inventory

|
By Omar I. Hajjaj, Tracy Cameron, Rebecca Barty, Dimpy Modi
| Wiley Online Library Verified
CAD canadian dollars COVID-19 coronavirus disease 2019 IU international units ORBCoN ontario regional blood coordinating network PDF portable document format RBC red blood cells 1 INTRODUCTION Total costs to prepare and distribute blood components (red blood cells, platelets, frozen plasma) and blood products (albumin, clotting factor concentrates, immune globulins) to Canadian hospitals surpasses $1 billion CAD annually.
Open in Who Shared Issue with article?

An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records

|
By Kiarash Riazi, Rebecca Barty, Jeannie Callum, Mark Ly
| Wiley Online Library Verified
1 INTRODUCTION Immunoglobulin (Ig) is a widely used human plasma product consisting of pooled antibodies from the plasma donated by healthy individuals.1 It is available in two forms: intravenous (IVIg)2, 3 and subcutaneous (SCIg)4, 5 and is mainly used either for Ig replacement therapy (for primary and secondary hypogammaglobulinemia) or in larger doses as an immunomodulatory treatment for autoimmune conditions.6 In Canada, Héma Québec manages the distribution of Ig products within Quebec,...
Open in Who Shared Issue with article?

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk

|
By Rebecca Barty, Andrew W. Shih, Matthew T.S. Yan, Allahna L. Elahie
| Wiley
ORIGINAL ARTICLE Andrew W. Shih Corresponding Author E-mail address: andrew.shih@medportal.ca https://orcid.org/0000-0001-7107-2595 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Correspondence Andrew W. Shih, Department of Pathology, Vancouver General Hospital, JPP1, room 1553, 855 West 12th Avenue, Vancouver, BC V5Z 1M9, Canada.
Open in Who Shared Issue with article?
See all 4 articles